Resolving inflammation and pain of sickle cell

Blood. 2019 Jan 17;133(3):190-191. doi: 10.1182/blood-2018-11-886259.

Abstract

In this issue of Blood, Matte et al demonstrate that sickle cell disease (SCD) disrupts inflammation-resolution programs in a mouse model of SCD, giving evidence for an entirely new way to treat this disease.

Publication types

  • Comment

MeSH terms

  • Anemia, Sickle Cell*
  • Docosahexaenoic Acids
  • Humans
  • Inflammation
  • Pain*

Substances

  • resolvin D1
  • Docosahexaenoic Acids